Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 21.12.2020 | EN | Official Journal of the European Union | C 443/25 |

---

Action brought on 21 October 2020 — Dermavita Company v EUIPO — Allergan Holdings France (JUVÉDERM VYBRANCE)

(Case T-635/20)

(2020/C 443/29)

Language of the case: English

Parties

Applicant: Dermavita Company SARL (Beirut, Lebanon) (represented by: D. Todorov, lawyer)

Defendant: European Union Intellectual Property Office (EUIPO)

Other party to the proceedings before the Board of Appeal: Allergan Holdings France SAS (Courbevoie, France)

Details of the proceedings before EUIPO

Proprietor of the trade mark at issue: Other party to the proceedings before the Board of Appeal

Trade mark at issue: European Union word mark JUVÉDERM VYBRANCE –European Union trade mark No 13 541 594

Procedure before EUIPO: Cancellation proceedings

Contested decision: Decision of the Fourth Board of Appeal of EUIPO of 24 August 2020 in Case R 1014/2020-4

Form of order sought

The applicant claims that the Court should:

|  |  |
| --- | --- |
| — | annul the contested decision; |

|  |  |
| --- | --- |
| — | ask EUIPO to deem the appeal filed; |

|  |  |
| --- | --- |
| — | order EUIPO and the other party to bear their own costs and pay those of the Applicant before the General Court. |

Plea in law

|  |  |
| --- | --- |
| — | Infringement of Articles 101(4), 104, 106 and 107 of Regulation (EU) 2017/1001 of the European Parliament and of the Council. |

---

[Top](#document1)